Astrana Health (ASTH) Short term Debt (2012 - 2026)

Astrana Health has reported Short term Debt for 13 years, with the latest figure at $47.9 million in Q1 2026.

• Quarterly Short term Debt rose 282.92% year-over-year to $47.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.9 million (up 282.92% YoY) and the FY2025 annual result came in at $47.9 million, up 410.56% from the prior year.
• Short term Debt was little changed at $47.9 million in Q1 2026 per ASTH's latest filing, from $47.9 million in the prior quarter.
• Over five years, Short term Debt peaked at $47.9 million in Q3 2025 and troughed at $619000.0 in Q4 2022.
• A 5-year average of $15.5 million and a median of $12.5 million in 2025 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2022 and 2024: Short term Debt slumped 87.56% in 2022, then jumped 3241.38% in 2024.
• Over 5 years, Short term Debt stood at $619000.0 in 2022, then soared by 3050.24% to $19.5 million in 2023, then sank by 51.92% to $9.4 million in 2024, then jumped by 410.56% to $47.9 million in 2025, then changed by 0.0% to $47.9 million in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $47.9 million, $47.9 million, and $47.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.